GeneHealth - Your precision medicine

Seborrhoeic Keratosis

Disease Details

Family Health Simplified

Buy Membership

Description: Seborrhoeic keratosis is a common, non-cancerous skin growth that appears as a brown, black, or light tan lesion with a waxy, scaly, slightly elevated appearance.
Type: Seborrhoeic keratosis is a benign skin growth. It is not typically associated with genetic transmission, though there may be a slight familial tendency, suggesting a genetic predisposition.
Signs And Symptoms: Seborrhoeic keratosis is a common benign skin condition.

### Signs and Symptoms:
1. **Appearance**: Waxy, wart-like growths that may be tan, brown, or black.
2. **Texture**: Slightly raised with a smooth or rough texture.
3. **Shape**: Typically round or oval.
4. **Size**: Varies from very small to more than 2.5 centimeters in diameter.
5. **Location**: Commonly found on the face, chest, shoulders, or back, but can appear anywhere on the body except the palms and soles.
6. **Number**: Can occur singly or in clusters.
7. **Growth**: Lesions may grow slowly and become more numerous with age.
8. **Symptoms**: Usually painless, but can become irritated or itch if rubbed against clothing.
Prognosis: Seborrhoeic keratosis is a benign skin condition, meaning it is non-cancerous and generally does not pose any significant health risks. The prognosis for seborrhoeic keratosis is excellent. The growths may increase in number and size over time, but they do not progress to skin cancer. Treatment, if desired for cosmetic reasons or irritation, typically involves cryotherapy, curettage, or laser therapy.
Onset: Seborrhoeic keratosis typically appears in middle age or later, often starting around age 50 or older. The exact cause is unclear, but genetics and cumulative sun exposure are thought to play roles. The growths develop gradually and are benign, presenting as wart-like lesions on the skin.
Prevalence: Seborrhoeic keratosis is a common benign skin growth, particularly prevalent among older adults. The prevalence increases with age, affecting a majority of individuals over 50. It is less common in younger people but can still occur.
Epidemiology: Seborrheic keratosis is the most common benign skin tumor. Incidence increases with age. There is less prevalence in people with darker skin. In large-cohort studies, all patients aged 50 and older had at least one seborrheic keratosis. Onset is usually in middle age, although they are common in younger patients too, as they are found in 12% of 15-year-olds to 25-year-olds, which makes the term "senile keratosis" a misnomer.
Intractability: Seborrhoeic keratosis is not considered an intractable condition. It is a benign skin growth that often appears in older adults. Treatment is generally optional and not medically necessary unless the lesions cause discomfort or cosmetic concerns. When treatment is desired, options such as cryotherapy, curettage, and laser therapy are typically effective.
Disease Severity: Seborrhoeic keratosis is typically considered a benign skin condition. While it can vary in appearance, these lesions are generally harmless and do not pose a serious health risk. They can sometimes be mistaken for other skin conditions, which may require a dermatologist’s evaluation for accurate diagnosis. Treatment is usually not necessary unless the lesions cause discomfort or cosmetic concern.
Healthcare Professionals: Disease Ontology ID - DOID:6498
Pathophysiology: Seborrhoeic keratosis is a benign skin condition characterized by the proliferation of immature keratinocytes. The pathophysiology involves the development of these growths likely due to genetic mutations and age-related factors, though the exact mechanisms are not fully understood. These lesions typically exhibit hyperkeratosis, acanthosis, and papillomatosis histologically, and they are often influenced by genetic predisposition and UV exposure. This condition is non-cancerous and primarily affects older adults.
Carrier Status: Seborrhoeic keratosis is a benign skin condition commonly seen in older adults. It is characterized by waxy, raised, wart-like growths on the skin. Carrier status is not applicable to seborrhoeic keratosis as it is not an infectious or inheritable disease.
Mechanism: Seborrhoeic keratosis is a common benign skin growth that typically appears in older adults. The exact mechanism underlying the development of seborrhoeic keratosis is not fully understood, but it is believed to involve a combination of genetic and environmental factors.

At the molecular level, several mechanisms have been implicated in the pathogenesis of seborrhoeic keratosis:

1. **Genetic Mutations**: Studies have identified mutations in genes involved in cell growth and proliferation. Notably, mutations in the FGFR3 (fibroblast growth factor receptor 3) and PIK3CA genes have been frequently found in seborrhoeic keratosis lesions. These mutations can lead to uncontrolled skin cell growth and accumulation.

2. **Activation of Signaling Pathways**: Alterations in key signaling pathways, such as the PI3K/AKT/mTOR pathway, have been observed. Mutations in PIK3CA, a gene encoding a subunit of PI3K, result in the activation of this pathway, promoting cellular growth and survival.

3. **Epidermal Growth Factor Receptor (EGFR) Pathway**: Increased activity of the EGFR signaling pathway has also been associated with seborrhoeic keratosis. This pathway is critical for cell proliferation and differentiation, and its dysregulation can contribute to the formation of these lesions.

4. **Ultraviolet (UV) Radiation**: Although not a direct cause, UV radiation may play a role in the development and progression of seborrhoeic keratosis by causing DNA damage and promoting mutations in skin cells.

Overall, the development of seborrhoeic keratosis involves a complex interplay of genetic mutations and abnormal activation of cellular signaling pathways that drive the proliferation of keratinocytes, the predominant cell type in the epidermis.
Treatment: Medical reasons for removing seborrheic keratoses include irritation and bleeding. They may also be removed for cosmetic reasons. Generally, lesions can be treated with electrodesiccation and curettage, or cryosurgery. When correctly performed, removal of seborrheic keratoses will not cause much visible scarring.
Compassionate Use Treatment: Seborrhoeic keratosis is generally considered benign and typically does not require treatment unless it becomes symptomatic or cosmetically concerning to the patient. For compassionate use treatment, off-label or experimental options may include:

1. **Topical Treatments**:
- **Topical Retinoids**: Although primarily used for acne and other skin conditions, retinoids may help in thinning seborrhoeic keratosis.
- **Hydroxy acids (e.g., glycolic acid, lactic acid)**: These are sometimes used off-label to exfoliate the skin and may reduce the appearance of lesions.

2. **Cryotherapy**:
- **Liquid Nitrogen**: This is an established method but can also be considered an off-label approach for smaller or less common presentations of lesions.

3. **Laser Therapy**:
- **Erbium:YAG or CO2 lasers**: These are often used off-label to remove seborrhoeic keratosis by vaporizing the lesion.

4. **Electrosurgery**:
- **Curettage and Electrocautery**: While widely practiced, these surgical options can sometimes fall under off-label usage for less conventional presentations.

5. **Topical Hydrogen Peroxide 40%**:
- Recently approved by the FDA for seborrhoeic keratosis, this treatment was previously used off-label or in experimental settings.

Exploration of these treatments should ideally be under the guidance of a dermatologist, considering the potential benefits and side effects.
Lifestyle Recommendations: Seborrhoeic keratosis, commonly known as age spots or skin barnacles, is a benign skin growth that typically doesn't require treatment. However, if you're prone to these growths or wish to manage them better, certain lifestyle recommendations might be helpful:

1. **Sun Protection**: Regularly use a broad-spectrum sunscreen with an SPF of 30 or higher to protect your skin from excessive UV exposure, which can cause skin changes.

2. **Skincare Routine**: Maintain a gentle skincare routine to keep your skin healthy. Avoid harsh chemicals and excessive exfoliation that can irritate the skin.

3. **Regular Skin Checks**: Monitor your skin for any new or changing growths. Although seborrhoeic keratoses are benign, it’s essential to differentiate them from other conditions like melanoma that require medical attention.

4. **Healthy Diet**: Eating a balanced diet rich in antioxidants, vitamins, and minerals supports overall skin health.

5. **Moisturization**: Keep your skin well-moisturized to prevent dryness, which can exacerbate the appearance of skin lesions.

Remember, while lifestyle changes can promote general skin health, they cannot prevent or remove seborrhoeic keratoses. If you're concerned about their appearance, consult a dermatologist for safe removal options.
Medication: Seborrhoeic keratosis is generally considered a benign and non-cancerous skin growth. There are no specific medications to treat seborrhoeic keratosis since it doesn't typically pose any health risks. However, for cosmetic or comfort reasons, treatments like cryotherapy (freezing the growth with liquid nitrogen), curettage (scraping the growth off), laser therapy, or electrocautery (burning the growth off with an electric current) might be used. Always consult with a dermatologist for the most appropriate treatment options.
Repurposable Drugs: Current research does not prominently identify specific repurposable drugs for seborrhoeic keratosis. The condition is benign and often does not require treatment unless for cosmetic reasons. Standard treatments involve cryotherapy, curettage, or laser therapy. However, some studies and anecdotal reports have considered topical agents like hydrogen peroxide or 5-fluorouracil as potential options, though their effectiveness and safety require further validation. For specific recommendations, consulting a dermatologist is advised.
Metabolites: Seborrhoeic keratosis is a benign skin growth that typically does not have specific metabolites associated with it. It arises from the proliferation of keratinocytes and does not have a metabolic component that can be targeted or diagnosed through metabolites. Therefore, information on specific metabolites for seborrhoeic keratosis is not applicable (nan).
Nutraceuticals: For seborrhoeic keratosis, there is no substantial evidence to support the use of nutraceuticals for treatment or prevention. The condition, characterized by benign skin growths, is typically managed with methods such as cryotherapy, curettage, or laser treatment. Always consult with a healthcare professional for appropriate diagnosis and treatment options.
Peptides: Seborrhoeic keratosis is a common, non-cancerous skin growth that often appears in older adults. It is not typically associated with peptides or nanoparticles in its treatment. Standard treatment options mainly focus on physical removal techniques such as cryotherapy, curettage, or laser therapy.